Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Melatonin  COVID-19 treatment studies for Melatonin  C19 studies: Melatonin  Melatonin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
Ramos et al., Antioxidants, doi:10.3390/antiox10071152 (Review)
Ramos et al., The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy, Antioxidants, doi:10.3390/antiox10071152 (Review)
Jul 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Review of melatonin for COVID-19 discussing mechanisms of action and ongoing trials.
Ramos et al., 20 Jul 2021, peer-reviewed, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperMelatoninAll
Abstract: antioxidants Review The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy Eva Ramos 1 , Francisco López-Muñoz 2,3,4,5 , Emilio Gil-Martín 6 , Javier Egea 7,8 , Iris Álvarez-Merz 9,10 , Sakshi Painuli 11 , Prabhakar Semwal 11,12 , Natália Martins 13,14 , Jesús M. Hernández-Guijo 9,10 and Alejandro Romero 1, * 1 2 3 4 5 6   Citation: Ramos, E.; López-Muñoz, F.; Gil-Martín, E.; Egea, J.; 7 8 9 Álvarez-Merz, I.; Painuli, S.; Semwal, P.; Martins, N.; Hernández-Guijo, 10 J.M.; Romero, A. The Coronavirus Disease 2019 (COVID-19): Key 11 Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants 12 2021, 10, 1152. https://doi.org/ 13 10.3390/antiox10071152 Academic Editors: Helen Galley and Juan Carlos Mayo Received: 19 June 2021 Accepted: 14 July 2021 Published: 20 July 2021 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article 14 * Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain; eva.ramos@ucm.es Faculty of Health Sciences, University Camilo José Cela, C/Castillo de Alarcón 49, Villanueva de la Cañada, 28692 Madrid, Spain; flopez@ucjc.edu Neuropsychopharmacology Unit, Hospital 12 de Octubre Research Institute (i + 12), Avda. Córdoba, s/n, 28041 Madrid, Spain Portucalense Institute of Neuropsychology and Cognitive and Behavioural Neurosciences (INPP), Portucalense University, R. Dr. António Bernardino de Almeida 541, 4200-072 Porto, Portugal Thematic Network for Cooperative Health Research (RETICS), Addictive Disorders Network, Health Institute Carlos III, MICINN and FEDER, 28029 Madrid, Spain Nutrition, Food & Plant Science Group NF1, Department of Biochemistry, Genetics and Immunology, Faculty of Biology, University of Vigo, 36310 Vigo, Spain; egil@uvigo.es Health Research Institute, Hospital Universitario de la Princesa, 28006 Madrid, Spain; javier.egea@inv.uam.es Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, 28006 Madrid, Spain Department of Pharmacology and Therapeutic, Teófilo Hernando Institute, Faculty of Medicine, Universidad Autónoma de Madrid, Av. Arzobispo Morcillo 4, 28029 Madrid, Spain; iris.alvarez@estudiante.uam.es (I.Á.-M.); jesusmiguel.hernandez@uam.es (J.M.H.-G.) Ramón y Cajal Institute for Health Research (IRYCIS), Hospital Ramón y Cajal, Carretera de Colmenar Viejo, Km. 9100, 28029 Madrid, Spain Department of Biotechnology, Graphic Era University, Dehradun, Uttarakhand 248002, India; sakshipainuli@geu.ac.in (S.P.); semwal.prabhakar@geu.ac.in (P.S.) Uttarakhand State Council for Science and Technology, Dehradun, Uttarakhand 248007, India Faculty of Medicine, Institute for Research and Innovation in Health (i3S), University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal; ncmartins@med.up.pt Institute for Research and Advanced Training in Health Sciences and Technologies, Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal Correspondence: manarome@ucm.es; Tel.: +34-913-943970 Abstract: Viral infections constitute a tectonic convulsion in the..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit